Exchange: OTC·Updated 12:52 PM EDT

ORPOFOSE Immunotherapeutics

$4.43
$0.00
(0.00%)
Today
EarningsSep 28
Mkt Cap$100.3M
Vol3,500.00

About

OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
64

Frequently Asked Questions

What is Market Cap of OSE Immunotherapeutics?
What is the 52-week high for OSE Immunotherapeutics?
What is the 52-week low for OSE Immunotherapeutics?
What is OSE Immunotherapeutics stock price today?
What is the PE ratio of OSE Immunotherapeutics?
What is the Price-to-Book ratio of OSE Immunotherapeutics?
What is the 50-day moving average of OSE Immunotherapeutics?
How many employees does OSE Immunotherapeutics have?

Latest ORPOF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.